The metabolic syndrome in children and adolescents

Paediatrics and Child Health

Volumn 10, Issue 1, 2005, Pages 41-47

  Hadjiyannakis, Stasia ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Cardiovascular disease; Insulin resistance; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; TRIACYLGLYCEROL;

ADOLESCENT; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; DIABETES MELLITUS; DIET THERAPY; DYSLIPIDEMIA; ETHNIC GROUP; EXERCISE; FAT INTAKE; GENETIC PREDISPOSITION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; REVIEW; RISK FACTOR; SCREENING TEST; SMALL FOR DATE INFANT; SYNDROME DELINEATION; TREATMENT INDICATION; WEIGHT REDUCTION;

EID: 14944355090     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/10.1.41     Document Type: Review

References (74)

1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4.
2. Isoma B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
3. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary artery disease, cardiovascular disease and all causes in United States adults. Circulation 2004;110:1245-50.
4. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-7.
5. Hanson RL, Imperatore G, Vennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002;51:3120-7.
6. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle aged-men. JAMA 2002;288:2709-16.
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III ) final report. Circulation 2002;106:3143-421.
8. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey, 1988-94. Arch Pediatr Adolesc Med 2003;57:821-7.
9. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
10. Chen W, Srinivasan SR, Elkasabany A, Betenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: The Bogalusa Heart Study. Am J Epidemiol 1999;150:667-74.
11. Raitakari OT, Porkka KV, Ronnemaa T, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia 1995;38:1042-50.
12. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004;89:108-13.
13. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998;338:1650-6.
14. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
15. 1c in U.S. adolescents: The Third National Health and Nutrition Examination Survey. Diabetes Care 2001;24:834-7.
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
17. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
18. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation of the European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-3.
19. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts and different goals. Endocrin Metab Clin N Am 2004;33:283-303.
20. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: The Bogalusa Heart Study. Diabetes 2000;49:1042-8.
21. Zimmet PZ, McCarty DJ, de Courten MP. The global epidemiology of non-insulin dependant diabetes mellitus and the metabolic syndrome. J Diabetes Complications 1997;11:60-8.
22. Sung RY, Tong PC, Yu CW, et al. High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care 2003;26:250-1.
23. Reaven GM. Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dysplipidemia and coronary heart disease. Am Heart J 1991;121:1283-8.
24. Liese AD, Mayer-Davis EJ, Tyroler HA, et al. Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI and WHR. Atherosclerosis risk in communities. Ann Epidemiol 1997;7:407-16.
25. Ferrannini E, Muscelli E, Stern MP, Haffner SM. Differential impact of insulin and obesity on cardiovascular risk in non-diabetic subjects, Int J Obes Relat Metab Disord 1996;20:7-14.
26. Sinaiko AR, Jacobs DR Jr, Steinberger J, et al. Insulin resistance syndrome in childhood: Associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001;139:700-7.
27. Srinivasan SR, Myers L, Berenson GM. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: The Bogalusa Heart Study. Diabetes 2002;51:204-9.
28. Vague J. The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956. Nutrition 1999;15:89-90.
29. Freedman DS, Serdula MK, Srinivasan SR, Berenson GS. Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: The Bogalusa Heart Study. Am J Clin Nutr 1999;69:308-17.
30. Katzmarzyk PT, Srinivasan SR, Chen W, Malina RM, Bouchard C, Berenson GS. Body mass index, waist circumference and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics 2004;114:e198-205.
31. Maffeis C, Petrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular disease risk factors in prepubertal children. Obes Res 2001;9:179-87.
32. Mei Z, Grummer-Strawn LM, Petrobelli A, Goulding A, Goran MI, Dietz WH. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 2002;75:975-85.
33. Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: A syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362:951-7.
34. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: A defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991;72:277-82.
35. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-73.
36. Bouchard C, Despres JP, Mauriege P. Genetic and non-genetic determinants of regional fat distribution. Endocr Rev 1993;34:72-93.
37. Srinivasan SR, Elkasabani A, Dalferes ER Jr, Bao W, Berenson GS. Characteristics of young offspring of type 2 diabetic parents in a biracial (black-white) community based sample: The Bogalusa Heart Study. Metabolism 1998;47:998-1004.
38. Srinivasan SR, Frontini MG, Berenson GS. Longitudinal changes in risk variables of insulin resistance syndrome from childhood to adulthood in offspring of parents with type 2 diabetes: The Bogalusa Heart Study. Metabolism 2003;52:443-50.
39. Grunfeld B, Balzareti M, Romo M, Gimenez M, Gutman R. Hyperinsulinemia in normotensive offspring of hypertensive parents. Hypertension 1994;23:12-5.
40. Vlasakova Z, Pelikanova T, Karasova L, Skibova J. Insulin secretion, sensitivity and metabolic profile of young, healthy offspring of hypertensive parents. Metabolism 2004;53:469-75.
41. Barker DJ. In utero programming of cardiovascular disease. Theriogenology 2000;53:555-74.
42. Wilkin TJ, Metcalfe BS, Murphy MJ, Kirby J, Jeffrey AN, Voss LD. The relative contributions of birth weight, weight change and current weight to insulin resistance in contemporary 5-year olds: The Early Bird Study. Diabetes 2002;51:3468-72.
43. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH, Knowler WC. Birth weight, type 2 diabetes and insulin resistance in Pima Indian children and young adults. Diabetes Care 1999;22:944-50.
44. Murtaugh MA, Jacobs DR, Moran A, Steinberger J, Sinaiko AR. Relation of birth weight to fasting insulin, insulin resistance and body size in adolescents. Diabetes Care 2003;26:187-92.
45. Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring; follow up research in the Pima Indians. J Matern Fetal Med 2000;9:86-8.
46. Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003;361:1861-5.
47. Bo S, Menato G, Gallo ML, et al. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 2004;83:335-40.
48. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078-82.
49. Frank S. Polycystic ovarian syndrome. N Engl J Med 1995;333:853-61.
50. Scarpitta AM, Sinagra D. Polycysytic ovarian syndrome and endocrine and metabolic disease. Gynecol Endocrinol 2000;14:392-5.
51. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Hasseltine F, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell, 1992:377-84.
52. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;28:165-74.
53. Lewy VD, Danadian K, Witchel SF, Arslanian S. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 2000;138:38-44.
54. Dunaif A. Insulin resistance and ovarian dysfunction. In: Moller D, ed. Insulin Resistance. New York: John Wiley, 1993:301-25.
55. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and beta cell dysfunction and risk of cardiovascular disease. J Clin Endocr Metab 2000;86:66-71.
56. Dunaif A. Insulin resistance and the polycystic ovarian syndrome: Mechanism and implications for pathogenesis. Endocrin Rev 1997;18:774-800.
57. Orio F Jr, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: An observational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004;89:3696-701. Erratum in: 2004;89:5621.
58. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
59. Scaffner F, Thasler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283-98.
60. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-9.
61. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-32.
62. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
63. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-5.
64. National Centre for Health Statistics: National Health and Nutrition Examination Survey. CDC growth charts: Body mass index for age, 2000. 〈;www.cdc.gov/growthcharts〉 (Version current at December 10, 2004).
65. Canadian Diabetes Association, Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;27(Suppl 2):S1-152.
66. Ku CY, Gower BA, Hunter GR, Goran MI. Racial differences in insulin secretion and sensitivity in prepubertal children: Role of physical fitness and physical activity. Obes Res 2000;8:506-15.
67. Kang HS, Gutin B, Barbeau P, et al. Physical training improves insulin resistance syndrome markers in obese adolescents. Med Sci Sports Exerc 2002;34:1920-7.
68. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002;106:143-60. Erratum in: 2002;106:1178.
69. Sondike SB, Copperman N, Jacobson MS, Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003;142:253-8.
70. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A reduced glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 2003;157:773-9.
71. Epstein LH, Myers MD, Raynor HA, Saelens BE. Treatment of pediatric obesity. Pediatrics 1998;101:554-70.
72. Wisotsky W, Swencionis C. Cognitive-behavioral approaches in the management of obesity. Adolesc Med 2003;14:37-48.
73. Pasquali R, Antenucci D, Casimirri F, et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989;68:173-9.
74. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:e55.